Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

COVID-19 and the differences in physiological background between children and adults and their clinical consequences

L. Kapustova, O. Petrovicova, P. Banovcin, M. Antosova, A. Bobcakova, I. Urbancikova, Z. Rennerova, M. Jesenak

. 2021 ; 70 (S2) : S209-S225. [pub] 20211216

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc22000863

The SARS-CoV-2 pandemic has indeed been one of the most significant problems facing the world in the last decade. It has affected (directly or indirectly) the entire population and all age groups. Children have accounted for 1.7 % to 2 % of the diagnosed cases of COVID-19. COVID-19 in children is usually associated with a mild course of the disease and a better survival rate than in adults. In this review, we investigate the different mechanisms which underlie this observation. Generally, we can say that the innate immune response of children is strong because they have a trained immunity, allowing the early control of infection at the site of entry. Suppressed adaptive immunity and a dysfunctional innate immune response is seen in adult patients with severe infections but not in children. This may relate to immunosenescence in the elderly. Another proposed factor is the different receptors for SARS-CoV-2 and their differences in expression between these age groups. In infants and toddlers, effective immune response to viral particles can be modulated by the pre-existing non-specific effect of live attenuated vaccines on innate immunity and vitamin D prophylaxis. However, all the proposed mechanisms require verification in larger cohorts of patients. Our knowledge about SARS-CoV-2 is still developing.

Citace poskytuje Crossref.org

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc22000863
003      
CZ-PrNML
005      
20220217135129.0
007      
ta
008      
220106s2021 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.934759 $2 doi
035    __
$a (PubMed)34913353
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Kapustová, Lenka $7 xx0238227 $u Centre for Primary Immunodeficiencies, Clinic of Paediatrics, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, University Hospital in Martin, Martin, Slovak Republic
245    10
$a COVID-19 and the differences in physiological background between children and adults and their clinical consequences / $c L. Kapustova, O. Petrovicova, P. Banovcin, M. Antosova, A. Bobcakova, I. Urbancikova, Z. Rennerova, M. Jesenak
504    __
$a Literatura
520    9_
$a The SARS-CoV-2 pandemic has indeed been one of the most significant problems facing the world in the last decade. It has affected (directly or indirectly) the entire population and all age groups. Children have accounted for 1.7 % to 2 % of the diagnosed cases of COVID-19. COVID-19 in children is usually associated with a mild course of the disease and a better survival rate than in adults. In this review, we investigate the different mechanisms which underlie this observation. Generally, we can say that the innate immune response of children is strong because they have a trained immunity, allowing the early control of infection at the site of entry. Suppressed adaptive immunity and a dysfunctional innate immune response is seen in adult patients with severe infections but not in children. This may relate to immunosenescence in the elderly. Another proposed factor is the different receptors for SARS-CoV-2 and their differences in expression between these age groups. In infants and toddlers, effective immune response to viral particles can be modulated by the pre-existing non-specific effect of live attenuated vaccines on innate immunity and vitamin D prophylaxis. However, all the proposed mechanisms require verification in larger cohorts of patients. Our knowledge about SARS-CoV-2 is still developing.
650    _2
$a mladiství $7 D000293
650    12
$a vývoj mladistvých $7 D041923
650    _2
$a dospělí $7 D000328
650    _2
$a věkové faktory $7 D000367
650    _2
$a COVID-19 $x imunologie $x patofyziologie $x terapie $x virologie $7 D000086382
650    _2
$a dítě $7 D002648
650    12
$a vývoj dítěte $7 D002657
650    _2
$a předškolní dítě $7 D002675
650    _2
$a interakce hostitele a patogenu $7 D054884
650    _2
$a lidé $7 D006801
650    _2
$a imunitní systém $x růst a vývoj $x patofyziologie $x virologie $7 D007107
650    _2
$a kojenec $7 D007223
650    _2
$a novorozenec $7 D007231
650    _2
$a prognóza $7 D011379
650    _2
$a hodnocení rizik $7 D018570
650    _2
$a rizikové faktory $7 D012307
650    _2
$a SARS-CoV-2 $x imunologie $x patogenita $7 D000086402
650    _2
$a stupeň závažnosti nemoci $7 D012720
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Petrovičová, Otília $7 xx0231034 $u Centre for Primary Immunodeficiencies, Clinic of Paediatrics, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, University Hospital in Martin, Martin, Slovak Republic
700    1_
$a Bánovčin, Peter, $d 1954- $7 xx0030319 $u Centre for Primary Immunodeficiencies, Clinic of Paediatrics, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, University Hospital in Martin, Martin, Slovak Republic
700    1_
$a Antošová, Martina $7 xx0269316 $u University Hospital in Martin, Martin, Slovak Republic
700    1_
$a Bobčáková, Anna $7 xx0231058 $u Centre for Primary Immunodeficiencies, Clinic of Pneumology and Phthisiology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, University Hospital in Martin, Martin, Slovak Republic
700    1_
$a Urbančíková, Ingrid, $d 1967- $7 xx0136407 $u Clinic of Paediatrics, Faculty of Medicine, P.J. Safarik University, Children Faculty Hospital, Kosice, Slovak Republic
700    1_
$a Rennerová, Zuzana, $d 1972- $7 xx0151070 $u Clinic of Paediatric Pulmonology and Phthisiology, Faculty of Medicine, Slovak Medical University, National Institute of Children's Diseases, Bratislava, Slovak Republic
700    1_
$a Jeseňák, Miloš, $d 1980- $7 xx0104191 $u Centre for Primary Immunodeficiencies, Clinic of Paediatrics, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, University Hospital in Martin, Martin, Slovak Republic $u Centre for Primary Immunodeficiencies, Clinic of Pneumology and Phthisiology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, University Hospital in Martin, Martin, Slovak Republic $u Department of Clinical Immunology and Allergology, University Hospital in Martin, Martin, Slovak Republic
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 70, Suppl. 2 (2021), s. S209-S225
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34913353 $y Pubmed
910    __
$a ABA008 $b A 4120 $c 266 $y p $z 0
990    __
$a 20220106 $b ABA008
991    __
$a 20220217135123 $b ABA008
999    __
$a ok $b bmc $g 1761110 $s 1152009
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 70 $c S2 $d S209-S225 $e 20211216 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
LZP    __
$b NLK118 $a Pubmed-20220106

Najít záznam

Citační ukazatele

Možnosti archivace